Martin, Stephen

Quantifying the effects of 16p11.2 copy number variants on brain structure: a multisite genetic-first study

Martin-Brevet, S., Rodríguez-Herreros, B., Nielsen, J. A., Moreau, C., Modenato, C., Maillard, A. M., Pain, A., Richetin, S., Jønch, A. E., Qureshi, A. Y., et al. (2018) · Biological Psychiatry

Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders

Cited by 75

Bupropion for adults with attention‐deficit hyperactivity disorder: Meta‐analysis of randomized, placebo‐controlled trials

Maneeton, N., Maneeton, B., Srisurapanont, M., & Martin, S. D. (2011) · Psychiatry and Clinical Neurosciences

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 60

Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials

Maneeton, N., Maneeton, B., Srisurapanont, M., & Martin, S. D. (2012) · BMC Psychiatry

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 51

Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry

Warren, A. E., Hamilton, R. M., Bélanger, S. A., Gray, C., Gow, R. M., Sanatani, S., Côté, J.-M., Lougheed, J., LeBlanc, J., Martin, S., et al. (2009) · Canadian Journal of Cardiology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 34

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD

Maneeton, B., Maneeton, N., Suttajit, S., Reungyos, J., Srisurapanont, M., & Martin, S. (2014) · Drug Design, Development and Therapy

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 27